References
- DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
- BorsboomGJvan PeltWvan HouwelingenHCvan VianenBGSchoutenJPQuanjerPHDiurnal variation in lung function in subgroups from two Dutch populationsAm J Respir Crit Care Med19991594 Pt 11163117110194161
- CalverleyPMLeeATowseLvan NoordJWitekTJKelsenSEffect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax2003581085586014514937
- McCarleyCHannemanSKPadhyeNSmolenskyMHA pilot home study of temporal variations of symptoms in chronic obstructive lung diseaseBiol Res Nurs20079182017633443
- PostmaDSKoëterGHvd MarkTWReigRPSluiterHJThe effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstructionChest19858756536573987377
- PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurr Med Res Opin20092582043204819569976
- PartridgeMRMiravitllesMStåhlEKarlssonNSvenssonKWelteTDevelopment and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPDEur Respir J20103619610419897551
- WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
- WelteTOptimising treatment for COPD – new strategies for combination therapyInt J Clin Pract20096381136114919624783
- PartridgeMRSchuermannWBeckmanOPerssonTPolanowskiTEffect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPDTher Adv Respir Dis20093411119734176
- Calle RubioMCasamorRMiravitllesMIdentification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC studyInt J Chron Obstruct Pulmon Dis2017122373238328848338
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- Soler-CataluñaJJMartínez-GarcíaMASánchezLSTorderaMPSánchezPRSevere exacerbations and BODE index: two independent risk factors for death in male COPD patientsRespir Med2009103569269919131231
- MiravitllesMSoler-CataluñaJJCalleMSpanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable PhaseArch Bronconeumol2017536324335 English, Spanish28477954
- Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol2012489331337 English, Spanish22341911
- JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- JonesPWQuirkFHBaveystockCMA self-complete measure of health status for chronic airflow limitationAm Rev Respir Dis19921456132113271595997
- EremencoSAlbuquerquePArnoldBJTrundellDHareendranATranslation and linguistic validation of two COPD symptom diaries (NiCSI and EMSCI) for use in 14 countriesValue Health2014177A600
- MiravitllesMMenezesALópez VarelaMVPrevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational studyRespir Med2018134626929413510
- MiravitllesMWorthHSoler CataluñaJJObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS studyRespir Res20141512225331383
- van BuulARKasteleynMJChavannesNHTaubeCPhysical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptomsRespir Res20181914929587841
- MarinJMBeehKMClemensAEarly bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)Int J Chron Obstruct Pulmon Dis2016111425143427418815
- RocheNChavannesNHMiravitllesMCOPD symptoms in the morning: impact, evaluation and managementRespir Res20131411224143997
- JonesPMiravitllesMvan der MolenTBeyond FEV1 in COPD – a review of patient-reported outcomes and their measurement using a new generation of instrumentsInt J Chron Obst Pulm Dis20127697709